US Stock MarketDetailed Quotes

Lexicon Pharmaceuticals (LXRX)

Watchlist
  • 2.350
  • -0.080-3.29%
Close Aug 12 15:59 ET
  • 2.360
  • +0.010+0.43%
Post 20:01 ET
1.05BMarket Cap-14.69P/E (TTM)

Lexicon Pharmaceuticals (LXRX) Earnings Dates, Reports & Conference Call

LXRX 2026 Q2 Earnings Dates & Summary

Currency:USDAug 6, 2026

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
4.00M
692.00K
-3.31M
Miss Est.
-86.15%
-97.60%
-82.69%
Net Income
-20.59M
-31.78M
-11.18M
Miss Est.
-733.19%
-1077.09%
-54.31%
Buy

Aug 11, 2026

LXRX Revenue, EPS and EBIT Estimates

Revenue

Net Profit

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 13.311M--
--2026/Q3-- / 2.830M--
Aug 6, 20262026/Q2692.000K / 3.998M--
May 7, 20262026/Q121.102M / 9.784M--
Mar 5, 20262025/Q45.493M / 3.142M--
DatePeriodRevenue/EstimateEarnings Call
--2026/Q4-- / 13.311M--
--2026/Q3-- / 2.830M--
Aug 6, 20262026/Q2692.000K / 3.998M--
May 7, 20262026/Q121.102M / 9.784M--
Mar 5, 20262025/Q45.493M / 3.142M--

Unlock Free Earnings Estimates

Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Ahead of the market open, US Treasury Secretary Bessent indicated that the United States and Iran are poised to reach an agreement the follo Show More